Stimulant intoxication including amphetamines, methamphetamine or methcathinone (Q40406): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Intoxicação por estimulantes, incluindo anfetaminas, metanfetamina e metcatinona, mas excluindo cafeína, cocaína e catinonas sintéticas é uma condição transitória clinicamente significativa, que se desenvolve durante ou logo após o consumo de anfetaminas ou outros estimulantes, caracterizada por perturbações em consciência, cognição, percepção, afeto, comportamento ou coordenação. Essas perturbações são causadas pelos efeitos farmacológicos conhecidos das anfetaminas ou outros estimulantes e sua intensidade está intimamente relacionada à quantidade de anfetaminas ou outros estimulantes consumida. Têm duração limitada, e diminuem à medida que as anfetaminas ou outros estimulantes são eliminados do corpo. Sintomas de apresentação podem incluir ansiedade, raiva, atenção prejudicada, hipervigilância, agitação psicomotora, ideação paranoide (possivelmente de intensidade delirante), alucinações auditivas transitórias, confusão transitória, mudanças na sociabilidade. Sudorese ou calafrios, nausea ou vômitos, e palpitações podem estar presentes. Sinais físicos podem incluir taquicardia, elevação da pressão arterial, dilatação pupilar, discinesias e distonias, e feridas na pele. Em casos raros, geralmente na intoxicação grave, o uso de estimulantes, incluindo anfetaminas, metanfetamina e metcatinona pode resultar em convulsões. | |||||||||||||||
| description / en | description / en | ||||||||||||||
Stimulant intoxication including amphetamines, methamphetamine and methcathinone but excluding caffeine, cocaine and synthetic cathinones is a clinically significant transient condition that develops during or shortly after the consumption of amphetamine or other stimulants that is characterised by disturbances in consciousness, cognition, perception, affect, behaviour, or coordination. These disturbances are caused by the known pharmacological effects of amphetamine or other stimulants and their intensity is closely related to the amount of amphetamine or other stimulant consumed. They are time-limited and abate as amphetamine or another stimulant is cleared from the body. Presenting features may include anxiety, anger, impaired attention, hypervigilance, psychomotor agitation, paranoid ideation (possibly of delusional intensity), transient auditory hallucinations, transitory confusion, and changes in sociability. Perspiration or chills, nausea or vomiting, and palpitations may be experienced. Physical signs may include tachycardia, elevated blood pressure, pupillary dilatation, dyskinesias and dystonias, and skin sores. In rare instances, usually in severe intoxication, use of stimulants including amphetamines, methamphetamine and methcathinone can result in seizures. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/1775535234 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:6C46.3 | |||||||||||||||
| Property / CURIE: CID11:6C46.3 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-6C46.3 | |||||||||||||||
| Property / Canary Token: dki-india-6C46.3 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: F15.0 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 06:12, 13 August 2026
Stimulant intoxication including amphetamines, methamphetamine and methcathinone but excluding caffeine, cocaine and synthetic cathinones is a clinically significant transient condition that develops during or shortly after the consumption of amphetamine or other stimulants that is characterised by disturbances in consciousness, cognition, perception, affect, behaviour, or coordination. These disturbances are caused by the known pharmacological effects of amphetamine or other stimulants and their intensity is closely related to the amount of amphetamine or other stimulant consumed. They are time-limited and abate as amphetamine or another stimulant is cleared from the body. Presenting features may include anxiety, anger, impaired attention, hypervigilance, psychomotor agitation, paranoid ideation (possibly of delusional intensity), transient auditory hallucinations, transitory confusion, and changes in sociability. Perspiration or chills, nausea or vomiting, and palpitations may be experienced. Physical signs may include tachycardia, elevated blood pressure, pupillary dilatation, dyskinesias and dystonias, and skin sores. In rare instances, usually in severe intoxication, use of stimulants including amphetamines, methamphetamine and methcathinone can result in seizures.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 6C46.3 |
||
| English | Stimulant intoxication including amphetamines, methamphetamine or methcathinone |
Stimulant intoxication including amphetamines, methamphetamine and methcathinone but excluding caffeine, cocaine and synthetic cathinones is a clinically significant transient condition that develops during or shortly after the consumption of amphetamine or other stimulants that is characterised by disturbances in consciousness, cognition, perception, affect, behaviour, or coordination. These disturbances are caused by the known pharmacological effects of amphetamine or other stimulants and their intensity is closely related to the amount of amphetamine or other stimulant consumed. They are time-limited and abate as amphetamine or another stimulant is cleared from the body. Presenting features may include anxiety, anger, impaired attention, hypervigilance, psychomotor agitation, paranoid ideation (possibly of delusional intensity), transient auditory hallucinations, transitory confusion, and changes in sociability. Perspiration or chills, nausea or vomiting, and palpitations may be experienced. Physical signs may include tachycardia, elevated blood pressure, pupillary dilatation, dyskinesias and dystonias, and skin sores. In rare instances, usually in severe intoxication, use of stimulants including amphetamines, methamphetamine and methcathinone can result in seizures. |
Statements
CID11:6C46.3
0 references
dki-india-6C46.3
0 references
Concluído
0 references
13 August 2026
0 references
